EUVIMEDEUVIMED entdecken
Crossref

Letter to the Editor: Early molecular switching with camizestrant in clinical practice

Murat Kiraci

Oncology in Clinical Practice · 15.01.2026 · 22

DOI: 10.5603/ocp.115264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Murat Kiraci.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kiraci, M. (2026). Letter to the Editor: Early molecular switching with camizestrant in clinical practice. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.115264

Vancouver

Kiraci M. Letter to the Editor: Early molecular switching with camizestrant in clinical practice. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.115264

BibTeX
@article{Kiraci2026,
  author = {Kiraci, Murat},
  title = {Letter to the Editor: Early molecular switching with camizestrant in clinical practice},
  journal = {Oncology in Clinical Practice},
  year = {2026},
  volume = {22},
  number = {0},
  doi = {10.5603/ocp.115264}
}
Kostenlos starten →